Share Price and Basic Stock Data
Last Updated: July 26, 2025, 2:35 pm
| PEG Ratio | 8.24 |
|---|
Quick Insight
Fortis Malar Hospitals Ltd is currently trading at ₹71.5, presenting a market capitalization of ₹134 crore, but its high price-to-earnings (P/E) ratio of 344 suggests that investors are paying a premium for earnings that are not clearly defined, as net profit figures remain unavailable. The return on equity (ROE) stands at a mere 0.56%, indicating inefficiency in generating profit from shareholders' equity, while the return on capital employed (ROCE) is slightly better at 0.83%. The absence of data on operational metrics such as operating profit margin (OPM) and borrowings raises further concerns about financial health. Without transparency in key performance indicators, potential investors should approach Fortis Malar with caution, as the lack of clear profitability and operational metrics could signal underlying issues in the company’s financial stability.
Competitors of Fortis Malar Hospitals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 52.3 Cr. | 156 | 206/145 | 6.75 | 115 | 2.24 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 27.5 Cr. | 26.2 | 46.4/18.3 | 137 | 25.5 | 0.00 % | 1.16 % | 0.76 % | 10.0 |
| Gian Lifecare Ltd | 16.0 Cr. | 15.4 | 27.0/12.1 | 5.64 | 19.2 | 0.00 % | 29.2 % | 24.6 % | 10.0 |
| Fortis Malar Hospitals Ltd | 129 Cr. | 68.8 | 98.7/51.0 | 331 | 16.1 | 61.8 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 23.6 Cr. | 4.36 | 9.50/3.40 | 0.77 | 2.49 | 0.00 % | 77.2 % | 84.8 % | 10.0 |
| Industry Average | 27,692.50 Cr | 821.05 | 125.77 | 95.59 | 3.02% | 16.02% | 14.76% | 9.04 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22.62 | 20.10 | 23.29 | 21.90 | 20.66 | 17.76 | 18.15 | 17.58 | 5.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 19.35 | 20.13 | 21.01 | 20.30 | 19.93 | 18.27 | 18.23 | 18.67 | 5.04 | 0.88 | 0.47 | 0.41 | 0.37 |
| Operating Profit | 3.27 | -0.03 | 2.28 | 1.60 | 0.73 | -0.51 | -0.08 | -1.09 | 0.48 | -0.88 | -0.47 | -0.41 | -0.37 |
| OPM % | 14.46% | -0.15% | 9.79% | 7.31% | 3.53% | -2.87% | -0.44% | -6.20% | 8.70% | ||||
| Other Income | 1.58 | 1.64 | 1.50 | 1.52 | 1.97 | 1.61 | 2.31 | 1.26 | 59.69 | 0.83 | 0.56 | 0.56 | 0.77 |
| Interest | 1.55 | 1.55 | 1.61 | 1.49 | 1.42 | 1.35 | 1.30 | 1.26 | 0.39 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 3.24 | 3.02 | 2.91 | 2.78 | 3.44 | 2.67 | 2.72 | 2.91 | 1.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.06 | -2.96 | -0.74 | -1.15 | -2.16 | -2.92 | -1.79 | -4.00 | 58.72 | -0.06 | 0.09 | 0.15 | 0.40 |
| Tax % | 850.00% | 0.00% | 491.89% | 0.00% | 223.15% | 0.00% | 0.00% | 0.25% | 7.95% | 0.00% | 0.00% | 93.33% | 10.00% |
| Net Profit | -0.45 | -2.96 | -4.38 | -1.15 | -6.99 | -2.93 | -1.79 | -4.00 | 54.05 | -0.06 | 0.09 | 0.01 | 0.36 |
| EPS in Rs | -0.24 | -1.58 | -2.34 | -0.61 | -3.73 | -1.56 | -0.96 | -2.13 | 28.84 | -0.03 | 0.05 | 0.01 | 0.19 |
Last Updated: May 31, 2025, 6:02 am
Below is a detailed analysis of the quarterly data for Fortis Malar Hospitals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Expenses, as of Mar 2025, the value is 0.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.41 Cr. (Dec 2024) to 0.37 Cr., marking a decrease of 0.04 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.37 Cr.. The value appears strong and on an upward trend. It has increased from -0.41 Cr. (Dec 2024) to -0.37 Cr., marking an increase of 0.04 Cr..
- For OPM %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
- For Other Income, as of Mar 2025, the value is 0.77 Cr.. The value appears strong and on an upward trend. It has increased from 0.56 Cr. (Dec 2024) to 0.77 Cr., marking an increase of 0.21 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Dec 2024) to 0.40 Cr., marking an increase of 0.25 Cr..
- For Tax %, as of Mar 2025, the value is 10.00%. The value appears to be improving (decreasing) as expected. It has decreased from 93.33% (Dec 2024) to 10.00%, marking a decrease of 83.33%.
- For Net Profit, as of Mar 2025, the value is 0.36 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Dec 2024) to 0.36 Cr., marking an increase of 0.35 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.19. The value appears strong and on an upward trend. It has increased from 0.01 (Dec 2024) to 0.19, marking an increase of 0.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:26 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108.38 | 117.93 | 129.61 | 140.56 | 149.19 | 144.59 | 111.87 | 69.24 | 86.18 | 85.95 | 59.01 | 0.00 |
| Expenses | 99.39 | 110.37 | 123.31 | 139.64 | 147.44 | 146.94 | 114.57 | 75.58 | 82.74 | 81.38 | 60.22 | 2.14 |
| Operating Profit | 8.99 | 7.56 | 6.30 | 0.92 | 1.75 | -2.35 | -2.70 | -6.34 | 3.44 | 4.57 | -1.21 | -2.14 |
| OPM % | 8.29% | 6.41% | 4.86% | 0.65% | 1.17% | -1.63% | -2.41% | -9.16% | 3.99% | 5.32% | -2.05% | |
| Other Income | 6.85 | 7.63 | 7.21 | 7.95 | 8.44 | 10.03 | 11.11 | 15.10 | 7.39 | 6.64 | 64.88 | 2.72 |
| Interest | 0.46 | 0.51 | 0.40 | 0.46 | 0.38 | 0.51 | 7.81 | 7.20 | 6.56 | 6.07 | 4.30 | 0.01 |
| Depreciation | 1.99 | 2.71 | 3.16 | 3.94 | 4.21 | 4.38 | 12.53 | 12.88 | 12.53 | 12.15 | 9.36 | 0.00 |
| Profit before tax | 13.39 | 11.97 | 9.95 | 4.47 | 5.60 | 2.79 | -11.93 | -11.32 | -8.26 | -7.01 | 50.01 | 0.57 |
| Tax % | 34.43% | 34.25% | 35.58% | 30.20% | 40.54% | 26.16% | -25.48% | -30.48% | 0.12% | 120.97% | 9.36% | 31.58% |
| Net Profit | 8.78 | 7.86 | 6.42 | 3.11 | 3.32 | 2.06 | -8.89 | -7.87 | -8.27 | -15.48 | 45.32 | 0.39 |
| EPS in Rs | 4.72 | 4.23 | 3.45 | 1.67 | 1.78 | 1.10 | -4.74 | -4.20 | -4.41 | -8.26 | 24.18 | 0.21 |
| Dividend Payout % | 10.60% | 11.84% | 14.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 175.93% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -10.48% | -18.32% | -51.56% | 6.75% | -37.95% | -531.55% | 11.47% | -5.08% | -87.18% | 392.76% | -99.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | -7.84% | -33.24% | 58.31% | -44.70% | -493.60% | 543.03% | -16.56% | -82.10% | 479.95% | -491.90% |
Fortis Malar Hospitals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -26% |
| 5 Years: | 15% |
| 3 Years: | 27% |
| TTM: | 105% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -11% |
| 3 Years: | -10% |
| Last Year: | 1% |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 1:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18.61 | 18.61 | 18.62 | 18.68 | 18.70 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 |
| Reserves | 66.20 | 72.63 | 79.02 | 80.87 | 84.35 | 86.62 | 77.65 | 69.99 | 61.37 | 45.42 | 90.71 | 11.45 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.34 | 57.17 | 53.41 | 46.40 | 0.00 | 0.00 |
| Other Liabilities | 16.67 | 19.68 | 32.55 | 31.14 | 46.03 | 45.46 | 32.80 | 23.18 | 27.37 | 27.42 | 6.41 | 6.62 |
| Total Liabilities | 101.48 | 110.92 | 130.19 | 130.69 | 149.08 | 150.84 | 193.55 | 169.10 | 160.91 | 138.00 | 115.88 | 36.83 |
| Fixed Assets | 17.63 | 17.71 | 24.50 | 24.59 | 23.79 | 21.85 | 81.08 | 68.52 | 57.62 | 47.41 | 0.00 | 0.00 |
| CWIP | 0.64 | 0.64 | 0.36 | 0.61 | 0.72 | 0.73 | 0.09 | 0.36 | 0.06 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 83.21 | 92.57 | 105.33 | 105.49 | 124.57 | 128.26 | 112.38 | 100.22 | 103.23 | 90.59 | 115.88 | 36.83 |
| Total Assets | 101.48 | 110.92 | 130.19 | 130.69 | 149.08 | 150.84 | 193.55 | 169.10 | 160.91 | 138.00 | 115.88 | 36.83 |
Below is a detailed analysis of the balance sheet data for Fortis Malar Hospitals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 18.76 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.76 Cr..
- For Reserves, as of Mar 2025, the value is 11.45 Cr.. The value appears to be declining and may need further review. It has decreased from 90.71 Cr. (Mar 2024) to 11.45 Cr., marking a decrease of 79.26 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 6.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.41 Cr. (Mar 2024) to 6.62 Cr., marking an increase of 0.21 Cr..
- For Total Liabilities, as of Mar 2025, the value is 36.83 Cr.. The value appears to be improving (decreasing). It has decreased from 115.88 Cr. (Mar 2024) to 36.83 Cr., marking a decrease of 79.05 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 36.83 Cr.. The value appears to be declining and may need further review. It has decreased from 115.88 Cr. (Mar 2024) to 36.83 Cr., marking a decrease of 79.05 Cr..
- For Total Assets, as of Mar 2025, the value is 36.83 Cr.. The value appears to be declining and may need further review. It has decreased from 115.88 Cr. (Mar 2024) to 36.83 Cr., marking a decrease of 79.05 Cr..
Notably, the Reserves (11.45 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.99 | 7.56 | 6.30 | 0.92 | 1.75 | -2.35 | -67.04 | -63.51 | -49.97 | -41.83 | -1.21 | -2.14 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
No data available for the Financial Efficiency data table.
No valid data available for the Shareholding
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.21 | 24.18 | -8.26 | -4.41 | -4.20 |
| Diluted EPS (Rs.) | 0.21 | 24.18 | -8.26 | -4.41 | -4.20 |
| Cash EPS (Rs.) | 0.20 | 29.15 | -1.78 | 2.27 | 2.67 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.11 | 58.36 | 34.21 | 42.72 | 47.31 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.11 | 58.36 | 34.21 | 42.72 | 47.31 |
| Revenue From Operations / Share (Rs.) | 0.00 | 31.46 | 45.82 | 45.94 | 36.92 |
| PBDIT / Share (Rs.) | 0.30 | 3.06 | 5.98 | 5.77 | 1.02 |
| PBIT / Share (Rs.) | 0.30 | -1.93 | -0.49 | -0.90 | -5.84 |
| PBT / Share (Rs.) | 0.30 | 26.66 | -3.74 | -4.40 | -6.03 |
| Net Profit / Share (Rs.) | 0.20 | 24.16 | -8.25 | -4.41 | -4.20 |
| NP After MI And SOA / Share (Rs.) | 0.20 | 24.16 | -8.25 | -4.41 | -4.20 |
| PBDIT Margin (%) | 0.00 | 9.74 | 13.04 | 12.56 | 2.76 |
| PBIT Margin (%) | 0.00 | -6.12 | -1.09 | -1.97 | -15.82 |
| PBT Margin (%) | 0.00 | 84.74 | -8.15 | -9.58 | -16.33 |
| Net Profit Margin (%) | 0.00 | 76.81 | -18.01 | -9.60 | -11.36 |
| NP After MI And SOA Margin (%) | 0.00 | 76.81 | -18.01 | -9.60 | -11.36 |
| Return on Networth / Equity (%) | 1.29 | 41.40 | -24.12 | -10.32 | -8.86 |
| Return on Capital Employeed (%) | 1.91 | -3.29 | -0.88 | -1.31 | -7.59 |
| Return On Assets (%) | 1.06 | 39.11 | -11.21 | -5.14 | -4.65 |
| Asset Turnover Ratio (%) | 0.00 | 0.46 | 0.57 | 0.52 | 0.38 |
| Current Ratio (X) | 5.15 | 17.68 | 2.66 | 1.56 | 2.43 |
| Quick Ratio (X) | 5.15 | 17.68 | 2.63 | 1.50 | 2.36 |
| Interest Coverage Ratio (X) | 56.70 | 1.34 | 1.85 | 1.65 | 0.26 |
| Interest Coverage Ratio (Post Tax) (X) | 39.43 | -1.93 | -1.55 | -0.26 | -1.04 |
| Enterprise Value (Cr.) | 119.90 | -20.82 | 80.00 | 95.58 | 90.44 |
| EV / Net Operating Revenue (X) | 0.00 | -0.35 | 0.93 | 1.11 | 1.31 |
| EV / EBITDA (X) | 207.33 | -3.62 | 7.14 | 8.83 | 47.25 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 1.48 | 1.04 | 1.25 | 1.50 |
| Price / BV (X) | 4.56 | 0.79 | 1.39 | 1.35 | 1.17 |
| Price / Net Operating Revenue (X) | 0.00 | 1.48 | 1.04 | 1.25 | 1.50 |
| EarningsYield | 0.00 | 0.51 | -0.17 | -0.07 | -0.07 |
After reviewing the key financial ratios for Fortis Malar Hospitals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has decreased from 24.18 (Mar 24) to 0.21, marking a decrease of 23.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has decreased from 24.18 (Mar 24) to 0.21, marking a decrease of 23.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 3. It has decreased from 29.15 (Mar 24) to 0.20, marking a decrease of 28.95.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.11. It has decreased from 58.36 (Mar 24) to 16.11, marking a decrease of 42.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.11. It has decreased from 58.36 (Mar 24) to 16.11, marking a decrease of 42.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 31.46 (Mar 24) to 0.00, marking a decrease of 31.46.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 2. It has decreased from 3.06 (Mar 24) to 0.30, marking a decrease of 2.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from -1.93 (Mar 24) to 0.30, marking an increase of 2.23.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.30. This value is within the healthy range. It has decreased from 26.66 (Mar 24) to 0.30, marking a decrease of 26.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 24.16 (Mar 24) to 0.20, marking a decrease of 23.96.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 24.16 (Mar 24) to 0.20, marking a decrease of 23.96.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 9.74 (Mar 24) to 0.00, marking a decrease of 9.74.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -6.12 (Mar 24) to 0.00, marking an increase of 6.12.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 84.74 (Mar 24) to 0.00, marking a decrease of 84.74.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 76.81 (Mar 24) to 0.00, marking a decrease of 76.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. It has decreased from 76.81 (Mar 24) to 0.00, marking a decrease of 76.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 15. It has decreased from 41.40 (Mar 24) to 1.29, marking a decrease of 40.11.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 10. It has increased from -3.29 (Mar 24) to 1.91, marking an increase of 5.20.
- For Return On Assets (%), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 5. It has decreased from 39.11 (Mar 24) to 1.06, marking a decrease of 38.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.46 (Mar 24) to 0.00, marking a decrease of 0.46.
- For Current Ratio (X), as of Mar 25, the value is 5.15. This value exceeds the healthy maximum of 3. It has decreased from 17.68 (Mar 24) to 5.15, marking a decrease of 12.53.
- For Quick Ratio (X), as of Mar 25, the value is 5.15. This value exceeds the healthy maximum of 2. It has decreased from 17.68 (Mar 24) to 5.15, marking a decrease of 12.53.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 56.70. This value is within the healthy range. It has increased from 1.34 (Mar 24) to 56.70, marking an increase of 55.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 39.43. This value is within the healthy range. It has increased from -1.93 (Mar 24) to 39.43, marking an increase of 41.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 119.90. It has increased from -20.82 (Mar 24) to 119.90, marking an increase of 140.72.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -0.35 (Mar 24) to 0.00, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 207.33. This value exceeds the healthy maximum of 15. It has increased from -3.62 (Mar 24) to 207.33, marking an increase of 210.95.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 1.48 (Mar 24) to 0.00, marking a decrease of 1.48.
- For Price / BV (X), as of Mar 25, the value is 4.56. This value exceeds the healthy maximum of 3. It has increased from 0.79 (Mar 24) to 4.56, marking an increase of 3.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 1.48 (Mar 24) to 0.00, marking a decrease of 1.48.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.51 (Mar 24) to 0.00, marking a decrease of 0.51.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fortis Malar Hospitals Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.91% (Industry Average ROCE: 16.02%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.29% (Industry Average ROE: 14.76%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 39.43
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.15
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 331 (Industry average Stock P/E: 125.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
Fortis Malar Hospitals Ltd. is a Public Limited Listed company incorporated on 13/04/1989 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L85110PB1989PLC045948 and registration number is 045948. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 18.76 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | Fortis Hospital, Sector 62, Mohali Punjab 160062 | secretarial.malar@malarhospitals.in http://www.fortismalarhospital.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Daljit Singh | Chairman (Non - Executive) & Non Independent Direc |
| Mr. Chandrasekar Ramasamy | Whole Time Director |
| Ms. Richa Singh Debgupta | Non Exe.Non Ind.Director |
| Ms. Shailaja Chandra | Independent Director |
| Ms. Suvalaxmi Chakraborty | Independent Director |
| Dr. Ritu Garg | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Fortis Malar Hospitals Ltd?
Fortis Malar Hospitals Ltd's intrinsic value (as of 26 July 2025) is 38.63 43.85% lower the current market price of 68.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 129 Cr. market cap, FY2025-2026 high/low of 98.7/51.0, reserves of 11.45 Cr, and liabilities of 36.83 Cr.
What is the Market Cap of Fortis Malar Hospitals Ltd?
The Market Cap of Fortis Malar Hospitals Ltd is 129 Cr..
What is the current Stock Price of Fortis Malar Hospitals Ltd as on 26 July 2025?
The current stock price of Fortis Malar Hospitals Ltd as on 26 July 2025 is 68.8.
What is the High / Low of Fortis Malar Hospitals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fortis Malar Hospitals Ltd stocks is ₹98.7/51.0.
What is the Stock P/E of Fortis Malar Hospitals Ltd?
The Stock P/E of Fortis Malar Hospitals Ltd is 331.
What is the Book Value of Fortis Malar Hospitals Ltd?
The Book Value of Fortis Malar Hospitals Ltd is 16.1.
What is the Dividend Yield of Fortis Malar Hospitals Ltd?
The Dividend Yield of Fortis Malar Hospitals Ltd is 61.8 %.
What is the ROCE of Fortis Malar Hospitals Ltd?
The ROCE of Fortis Malar Hospitals Ltd is 0.83 %.
What is the ROE of Fortis Malar Hospitals Ltd?
The ROE of Fortis Malar Hospitals Ltd is 0.56 %.
What is the Face Value of Fortis Malar Hospitals Ltd?
The Face Value of Fortis Malar Hospitals Ltd is 10.0.